Adelaide Research & Scholarship: Search

Search

Search:
for

Current filters:

Start a new search

Add filters:

Results/Page | Sort items by In order Authors/record

Results 11-20 of 23 (Search time: 0.002 seconds).

Item hits:

Preview	Issue Date	Title	Author(s)
	2011	Anterior 180-degree partial fundoplication: A 16-year experience with 548 patients	Chen, Z.; Thompson, S.; Jamieson, G.; Devitt, P.; Game, P.; Watson, D.
	2010	Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the diamond study	Dent, J.; Vakil, N.; Jones, R.; Bytzer, P.; Schnoning, U.; Halling, K.; Junghard, O.; Lind, T.
	2010	Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study	Saeed, P.; Blank, L.; Selva-Nayagam, D.; Wolbers, J.; Nowak, P.; Geskus, R.; Weis, E.; Mourits, M.; Rootman, J.
	2013	Smoking termination opportunity for in patients (STOP): Superiority of a course of varenicline tartrate plus counselling over counselling alone for smoking cessation: A 12-month randomised controlled trial for inpatients	Smith, B.; Carson, K.; Brinn, M.; Labiszewski, N.; Peters, M.; Fitridge, R.; Koblar, S.; Jannes, J.; Veale, A.; Goldsworthy, S.; Litt, J.; Edwards, D.; Esterman, A.
	2010	Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)	Hughes, T.; Hochhaus, A.; Branford, S.; Muller, M.; Kaeda, J.; Foroni, L.; Druker, B.; Guilhot, F.; Larson, R.; O'Brien, S.; Rudoltz, M.; Mone, M.; Wehrle, E.; Modur, V.; Goldman, J.; Radich, J.
	2010	Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity Study	Cortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.
	2015	Recent trends in early stage response to combination antiretroviral therapy in Australia	McManus, H.; Hoy, J.; Woolley, I.; Boyd, M.; Kelly, M.; Mulhall, B.; Roth, N.; Petoumenos, K.; Law, M.
	2013	The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand	Tang, W.; Bose, B.; McDonald, S.; Hawley, C.; Badve, S.; Boudville, N.; Brown, F.; Clayton, P.; Campbell, S.; Peh, C.; Johnson, D.
	2010	Canalicular lacerations: Repair with the Mini-Monoka (R) monocanalicular intubation stent	Leibovitch, I.; Kakizaki, H.; Prabhakaran, V.; Selva-Nayagam, D.
	2013	L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial	Ralph, A.; Waramori, G.; Pontororing, G.; Kenangalem, E.; Wiguna, A.; Tjitra, E.; Sandjaja,; Lolong, D.; Yeo, T.; Chatfield, M.; Soemanto, R.; Bastian, I.; Lumb, R.; Maguire, G.; Eisman, J.; Price, R.; Morris, P.; Kelly, P.; Anstey, N.; von Seidlein, L.